Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) in Africa, Europe, Asia, and North and South America. It offers metformin HCl; metformin direct compressible; and metformin premixed with lubricant magnesium stearate for use in plain metformin immediate release tablets. The company was founded in 1969 and is based in Oslo, Norway.
Frequently asked questions
What sector does Vistin Pharma ASA (VISTN) operate in?
Vistin Pharma ASA belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Vistin Pharma ASA (VISTN) current stock price?
As of the latest data, Vistin Pharma ASA stock price is NOK 18.10, with a previous close of NOK 18.35. Vistin Pharma ASA lost -NOK 0.25 in the last trading session, representing a -1.36% loss.
What is Vistin Pharma ASA (VISTN) current market capitalization?
Vistin Pharma ASA market cap is approximately 802.64 million.
What is Vistin Pharma ASA (VISTN) Earnings Per Share (EPS)?
The trailing EPS is NOK 1.59.
What is Vistin Pharma ASA (VISTN) Price-to-Earnings (P/E) ratio?
Vistin Pharma ASA current P/E ratio is 11.38.
What is Vistin Pharma ASA (VISTN) EBITDA?
Vistin Pharma ASA EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 28.20 million.
Does Vistin Pharma ASA (VISTN) pay dividends?
Yes. Vistin Pharma ASA pays semiannual dividends with an annualized yield of 11.05% and an estimated annual payout of NOK 2.00 per share.
When is the next ex-dividend date for Vistin Pharma ASA (VISTN)?
The next ex-dividend date is scheduled for November 22, 2026.
When is Vistin Pharma ASA (VISTN) next earnings report?
Vistin Pharma ASA is expected to release its next earnings report on September 30, 2026.
What is Vistin Pharma ASA (VISTN) beta (volatility) score?
Vistin Pharma ASA has a beta of 0.578, indicating lower volatility than the overall market.
